Call for papers - Artificial intelligence: applications in cardiovascular medicine

Guest Editors

Michael Spartalis, MD, PhD, FESC, FEHRA, FACC, CCDS, CEPS-A, 3rd Department of Cardiology, National and Kapodistrian University of Athens, Greece
Kanhua Yin, MD, MPH, Department of Surgery, University of Missouri–Kansas City, US

Submission Status: Open | Submission Deadline: 21 November 2024

BMC Cardiovascular Disorders is calling for submissions to our Collection on Artificial intelligence: applications in cardiovascular medicine. The progress in artificial intelligence (AI) holds promise for transforming cardiovascular medicine through its ability to facilitate novel methods for diagnosis, treatment, and prevention. Amidst this era of swift technological progress, AI stands poised to aid in early detection, risk evaluation, and prognostic assessment through the analysis of extensive datasets, ultimately resulting in enhanced patient outcomes and more effective management tactics.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 10: Reduced Inequalities.

Submit to Collection

Meet the Guest Editors

Back to top

Michael Spartalis, MD, PhD, FESC, FEHRA, FACC, CCDS, CEPS-A, 3rd Department of Cardiology, National and Kapodistrian University of Athens, Greece

Dr Michael Spartalis is an Attending Cardiologist, Certified Electrophysiology Specialist, and Certified Cardiac Device Specialist. Currently, a Cardiac Electrophysiologist at the 3rd Department of Cardiology, National and Kapodistrian University of Athens, Clinical Scholar at Harvard Medical School, and an Expert on medical devices at the European Commission and the European Medicines Agency. His work focuses on cardiac electrophysiology, device therapy, and sudden cardiac death, and encompasses a wide array of studies related to implantable cardioverter-defibrillators, cardiac resynchronization therapy, rhythm disturbances, and technology innovations including new disruptive wearable technologies improving health care delivery. He holds an MD and a PhD from National and Kapodistrian University of Athens, Medical School, a MSc in Thrombosis, Haemorrhage and Transfusion medicine from National and Kapodistrian University of Athens, Medical School, a MHCM from Conservatoire National des Arts et Métiers, and a Master in Interventional Electrophysiology from Università Vita-Salute San Raffaele. Most recently, he completed the Oxford Leadership Program.

Kanhua Yin, MD, MPH, Department of Surgery, University of Missouri–Kansas City, US

Dr Kanhua Yin is a surgery resident at the University of Missouri-Kansas City. With a background in clinical medicine and data science, he possesses a deep-seated passion for research in cardiovascular surgery, population-based outcomes analysis, clinical informatics, and natural language processing. Dr Yin boasts an impressive portfolio with over 80 peer-reviewed publications. His first-authored papers have been included in multiple international clinical guidelines, including the 2022 ACC/AHA aortic disease guideline and the 2024 ESVS abdominal aorto-iliac artery aneurysms guideline.

About the Collection

BMC Cardiovascular Disorders is calling for submissions to our Collection on Artificial intelligence: applications in cardiovascular medicine. Advancements in artificial intelligence (AI) have the potential to revolutionize cardiovascular medicine by enabling innovative approaches to diagnosis, treatment, and prevention. In this era of rapid technological advancements, AI can assist in early detection, risk assessment, and prognostic evaluation by analyzing large datasets, thus leading to improved patient outcomes and better management strategies.

BMC Cardiovascular Disorders is launching this Collection in alignment with the United Nations' Sustainable Development Goals (SDGs) 3: Good Health and Well-being and 10: Reduced Inequalities. The aim of this Collection is to consolidate both fundamental and clinical research to advance our comprehension of cardiovascular conditions.

BMC Cardiovascular Disorders welcomes original research on the design, implementation, optimization, and clinical impact of AI applications in the field of cardiovascular medicine. Topics of interest include, but are not limited to, the following:

• Machine learning (ML) algorithms for early detection of cardiovascular diseases
• AI applications for diagnostic accuracy studies
• AI systems as an intervention in live clinical settings
• Predictive modeling using AI for personalized risk assessment of cardiovascular disorders
• Application of AI in cardiovascular imaging analysis
• Utilizing natural language processing (NLP) and AI for analyzing electronic health records in cardiovascular care
• Application of AI and ML in cardiovascular surgery
• Wearable devices and AI algorithms for continuous monitoring of cardiovascular health
• AI-enabled precision medicine approaches for personalized treatment
• AI-powered automated risk scoring systems for cardiovascular events
• Ethical considerations and challenges in the implementation of AI in cardiovascular medicine
• AI in cardiovascular genetics
• Clinical decision support tools in cardiovascular medicine

We encourage the use of standardized reporting guidelines for research with AI/ML components to encourage authors to provide information to allow their work to be evaluated appropriately. Reporting guidelines and checklists have been developed for a broad range of study design and research types with AI/ML components. Those that have been developed, adapted, or are planned to be adapted for research using AI/ML can be found summarized in the table below:

Reporting guideline	AI guideline	Study design	AI- guideline description
SPIRIT, 2013	SPIRIT-AI, 2020	Randomized controlled trials (protocols)	Used to report the protocols of randomized controlled trials evaluating AI systems as interventions.
CONSORT, 2010	CONSORT-AI, 2020	Randomized controlled trials	Used to report randomized controlled trials evaluating AI systems as interventions (large-scale, summative evaluation), independently of the AI system modality (diagnostic, prognostic, therapeutic). Focuses on effectiveness and safety.
TRIPOD, 2015	TRIPOD-AI, upcoming	Prediction model evaluation	Used to report prediction models (diagnostic or prognostic) development, validation and updates.
STARD, 2015	STARD-AI	Diagnostic accuracy studies	Used to report diagnostic accuracy studies, either at development stage or as an offline validation in clinical settings.
N/A	CLAIM , 2020	Diagnostic accuracy studies	Used to report a wide spectrum of AI applications using medical images. Contains elements of the STARD 2015 guideline. Lists information such as descriptions of ground truth, data partitions, model description, and training and evaluation steps.
N/A	DECIDE-AI, 2022	Various (e.g. prospective cohort studies and non-randomized controlled trials) with additional features, such as modification of intervention, analysis of pre-specified subgroups or learning curve analysis.	Used to report the early evaluation of AI systems as an intervention in live clinical settings (small-scale, formative evaluation), independently of the study design and AI system modality (diagnostic, prognostic, therapeutic). Focuses on clinical utility, safety and human factors.

Image credit: Who is Danny / stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Artificial intelligence: applications in cardiovascular medicine" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.